Skip to main content
SpringerLink
Log in

Epidemiology of Primary Central Nervous System Lymphoma

  • Chapter
  • First Online:
Lymphoma and Leukemia of the Nervous System

Abstract

Primary central nervous system lymphoma (PCNSL) is commonly lethal, affects vulnerable immunosuppressed populations, and continues to increase in incidence among immunocompetent individuals in several countries. During the last decades, epidemiological studies from different parts of the world have demonstrated varying incidence rates of PCNSL, as well as discrepant findings concerning whether the incidence of PCNSL is increasing or stable. These findings suggest that there may be some factor or factors other than immunodeficiency that either causes or increases the susceptibility of an individual to PCNSL.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Mrugala MM, Rubenstein JL, Ponzoni M, Batchelor TT (2009 Jan) Insights into the biology of primary central nervous system lymphoma. Curr Oncol Rep 11(1):73–80; review

    Article  PubMed  CAS  Google Scholar 

  2. Cady FM, O’Neill BP, Law ME et al (2008) Del(6)(q22) and BCL6 rearrangements in primary CNS lymphoma are indicators of an aggressive clinical course. J Clin Oncol 26:4814–4819

    Article  PubMed  CAS  Google Scholar 

  3. Tun HW, Personett D, Baskerville KA et al (2008 Mar 15) Pathway analysis of primary central nervous system lymphoma. Blood 111(6):3200–3210

    Article  PubMed  CAS  Google Scholar 

  4. Blay JY, Conroy T, Chevreau C et al (1998 Mar) High-dose methotrexate for the treatment of primary cerebral lymphomas: analysis of survival and late neurologic toxicity in a retrospective series. J Clin Oncol 16(3):864–871

    PubMed  CAS  Google Scholar 

  5. Eby NL, Grufferman S, Flannelly CM et al (1988) Increasing incidence of primary brain lymphoma in the US. Cancer 62:2461–2465

    Article  PubMed  CAS  Google Scholar 

  6. Hochberg FH, Miller DC (1988) Primary central nervous system lymphoma. J Neurosurg 68:835–853

    Article  PubMed  CAS  Google Scholar 

  7. Levitt LJ, Dawson DM, Rosenthal DS, Moloney WC (1980) CNS involvement in the non-Hodgkin’s lymphomas. Cancer 45:545–552

    Article  PubMed  CAS  Google Scholar 

  8. Cote TR, Manns A, Hardy CR et al (1996) Epidemiology of brain lymphoma among people with or without acquired immunodeficiency syndrome. AIDS/Cancer Study Group. J Natl Cancer Inst 88:675–679

    Article  PubMed  CAS  Google Scholar 

  9. Corn BW, Marcus SM, Topham A et al (1997) Will primary central nervous system lymphoma be the most frequent brain tumor diagnosed in the year 2000? Cancer 79:2409–2413

    Article  PubMed  CAS  Google Scholar 

  10. Miller DC, Hochberg FH, Harris NL et al (1994) Pathology with clinical correlations of primary central nervous system non-Hodgkin’s lymphoma. The Massachusetts General Hospital experience 1958–1989. Cancer 74:1383–1397

    Article  PubMed  CAS  Google Scholar 

  11. Olson JE, Janney CA, Rao RD et al (2002) The continuing increase in the incidence of primary central nervous system non-Hodgkin lymphoma: a surveillance, epidemiology, and end results analysis. Cancer 95:1504–1510

    Article  PubMed  Google Scholar 

  12. Lutz JM, Coleman MP (1994) Trends in primary cerebral lymphoma. Br J Cancer 70:716–718

    Article  PubMed  CAS  Google Scholar 

  13. van der Sanden GA, Schouten LJ, van Dijck JA et al (2002) Primary central nervous system lymphomas: incidence and survival in the Southern and Eastern Netherlands. Cancer 94:1548–1556

    Article  PubMed  Google Scholar 

  14. Makino K, Nakamura H, Kino T et al (2006) Rising incidence of primary central nervous system lymphoma in Kumamoto, Japan. Surg Neurol 66:503–506

    Article  PubMed  Google Scholar 

  15. Haldorsen IS, Krossnes BK, Aarseth JH et al (2007) Increasing incidence and continued dismal outcome of primary central nervous system lymphoma in Norway 1989–2003: time trends in a 15-year national survey. Cancer 110:1803–1814

    Article  PubMed  Google Scholar 

  16. Hao D, DiFrancesco LM, Brasher PM et al (1999) Is primary CNS lymphoma really becoming more common? A population-based study of incidence, clinicopathological features and outcomes in Alberta from 1975 to 1996. Ann Oncol 10:65–70

    Article  PubMed  CAS  Google Scholar 

  17. Krogh-Jensen M, D’Amore F, Jensen MK et al (1994) Incidence clinicopathological features and outcome of primary central nervous system lymphomas. Population-based data from a Danish lymphoma registry. Danish Lymphoma Study Group, LYFO. Ann Oncol 5:349–354

    PubMed  CAS  Google Scholar 

  18. Yau YH, O’Sullivan MG, Signorini D et al (1996) Primary lymphoma of central nervous system in immunocompetent patients in south-east Scotland. Lancet 348:890

    Article  PubMed  CAS  Google Scholar 

  19. Au WY, Chan AC, Srivastava G et al (2000) Incidence and pathology of primary brain lymphoma in Hong Kong Chinese patients. Leuk Lymphoma 37:175–179

    Article  PubMed  CAS  Google Scholar 

  20. Powari M, Radotra B, Das A, Banerjee AK (2002) A study of primary central nervous system lymphoma in northern India. Surg Neurol 57:113–116

    Article  PubMed  Google Scholar 

  21. Tomlinson FH, Kurtin PJ, Suman VJ et al (1995) Primary intracerebral malignant lymphoma: a clinicopathological study of 89 patients. J Neurosurg 82:558–566

    Article  PubMed  CAS  Google Scholar 

  22. Chamberlain MC, Kormanik PA (1999) AIDS-related central nervous system lymphomas. J Neurooncol 43:269–276

    Article  PubMed  CAS  Google Scholar 

  23. Diamond C, Taylor TH, Aboumrad T, Anton-Culver H (2006) Changes in acquired immunodeficiency syndrome-related non-Hodgkin lymphoma in the era of highly active antiretroviral therapy: incidence, presentation, treatment, and survival. Cancer 106:128–135

    Article  PubMed  CAS  Google Scholar 

  24. Kirk O, Pedersen C, Cozzi-Lepri A et al (2001) Non-Hodgkin lymphoma in HIV-infected patients in the era of highly active antiretroviral therapy. Blood 98:3406–3412

    Article  PubMed  CAS  Google Scholar 

  25. Wolf T, Brodt HR, Fichtlscherer S et al (2005) Changing incidence and prognostic factors of survival in AIDS-related non-Hodgkin’s lymphoma in the era of highly active antiretroviral therapy (HAART). Leuk Lymphoma 46:207–215

    Article  PubMed  Google Scholar 

  26. Ammassari A, Cingolani A, Pezzotti P et al (2000) AIDS-related focal brain lesions in the era of highly active antiretroviral therapy. Neurology 55:1194–1200

    PubMed  CAS  Google Scholar 

  27. Besson C, Goubar A, Gabarre J et al (2001) Changes in AIDS-related lymphoma since the era of highly active antiretroviral therapy. Blood 98:2339–2344

    Article  PubMed  CAS  Google Scholar 

  28. Haldorsen IS, Krakenes J, Goplen AK et al (2008) AIDS-related primary central nervous system lymphoma: a Norwegian national survey 1989–2003. BMC Cancer 8:225

    Article  PubMed  Google Scholar 

  29. Kasamon YL, Ambinder RF (2005) AIDS-related primary central nervous system lymphoma. Hematol Oncol Clin North Am 19:665–687

    Article  PubMed  Google Scholar 

  30. Cingolani A, Fratino L, Scoppettuolo G, Antinori A (2005) Changing pattern of primary cerebral lymphoma in the highly active antiretroviral therapy era. J Neurovirol 11 Suppl 3:38–44

    Article  PubMed  Google Scholar 

  31. O’Neill BP, Kelly PJ, Earle JD et al (1987) Computer-assisted sterotactic biopsy for the diagnosis of primary central nervous system lymphoma. Neurology 37:1160–1164

    PubMed  Google Scholar 

  32. Mohile NA, Abrey LE (2007) Primary central nervous system lymphoma. Semin Radiat Oncol 17:223–229

    Article  PubMed  Google Scholar 

  33. Schabet M (1999) Epidemiology of primary CNS lymphoma. J Neurooncol 43:199–201

    Article  PubMed  CAS  Google Scholar 

  34. Snannoudj R, Durrbach A, Leblond V et al (2003) Primary brain lymphomas after kidney transplantation presentation and outcome. Transplantation 76:930–937

    Article  Google Scholar 

  35. O’Neill BP, Vernino S, Dogan A et al (2007) EBV-associated lymphoproliferative disorder of CNS associated with the use of mycophenolate mofetil. Neurooncol 9:364–369

    Google Scholar 

  36. Kleinschmidt-DeMasters BK, Damek DM, Lillehe KO et al (2008) Epstein Barr virus-associated primary CNS lymphomas in elderly patients on immunosuppressive medications. J Neuropathol Exp Neurol 67(11):1103–1111

    Article  PubMed  CAS  Google Scholar 

  37. Ferreri AJ, Reni M (2007) Primary central nervous system lymphoma. Crit Rev Oncol Hematol 63:257–268

    Article  PubMed  Google Scholar 

  38. Gates AE, Kaplan LD (2002) AIDS malignancies in the era of highly active antiretroviral therapy. Oncology 16:657–665

    PubMed  Google Scholar 

  39. Nakamura M, Shimada K, Ishida E, Konishi N (2004) Histopathology pathogenesis and molecular genetics in primary central nervous system lymphomas. Histol Histopathol 19:211–219

    PubMed  CAS  Google Scholar 

  40. Paulus W (1999) Classification, pathogenesis and molecular pathology of primary CNS lymphomas. J Neurooncol 43:203–208

    Article  PubMed  CAS  Google Scholar 

  41. Nicholas J (2007) Human herpesvirus 8 encoded proteins with potential roles in virus-associated neoplasia. Front Biosci 12:265–281

    Article  PubMed  CAS  Google Scholar 

  42. Schiff D, Suman VJ, Yang P et al (1998) Risk factors for primary central nervous system non-Hodgkin’s lymphoma (PCNSL). Cancer 82:975–992

    Article  PubMed  CAS  Google Scholar 

  43. DeAngelis LM (1991) Primary central nervous system lymphoma as a secondary malignancy. Cancer 67:1431–1435

    Article  PubMed  CAS  Google Scholar 

  44. Reni M, Ferreri AJ, Zoldan MC, Villa E (1997) Primary brain lymphomas in patients with a prior or concomitant malignancy. J Neurooncol 32:135–142

    Article  PubMed  CAS  Google Scholar 

  45. Pulido JS, Vierkant RA, Olson JE et al (2009 Jun) Racial differences in primary central nervous system lymphoma incidence and survival rates. Neurooncol 11(3):318–322

    Google Scholar 

  46. Camilleri-Broet S, Criniere E, Broet P et al (2006) A uniform activated B-cell-like immunophenotype might explain the poor prognosis of primary central nervous system lymphomas: analysis of 83 cases. Blood 107:190–196

    Article  PubMed  CAS  Google Scholar 

  47. Braaten KM, Betensky RA, de Leval L et al (2003) BCL-6 expression predicts improved survival in patients with primary central nervous system lymphoma. Clin Cancer Res 9:1063–1069

    PubMed  CAS  Google Scholar 

  48. Levy O, DeAngelis LM, Fillipa DA et al (2008) Bcl-6 predicts improved prognosis in primary central nervous system lymphoma. Cancer 112(1):151–156

    Article  PubMed  Google Scholar 

  49. Montesinos-Rongen M, Brunn A, Bentink S et al (2008) Gene expression profiling suggests primary central nervous system lymphomas to be derived from a late germinal center B cell. Leukemia 22:400–405

    Article  PubMed  CAS  Google Scholar 

  50. Algazi AP, Kadoch C, Rubenstein JL (2009) Biology and treatment of primary central nervous system lymphoma. Neurotherapeutics 6:587–597

    Article  PubMed  CAS  Google Scholar 

  51. Rubenstein J, Ferreri AJM, Pittaluga S (2008) Primary lymphoma of the central nervous system: epidemiology, pathology and current approaches to diagnosis, prognosis and treatment. Leuk Lymphoma 49:32–51

    Article  Google Scholar 

  52. Thelander EF, Ichimura K, Corcoran M et al (2008) Characterization of 6q deletions in mature B-cell lymphomas and childhood acute lymphoblastic leukemia. Leuk Lymphoma 49(3):477–487

    Article  PubMed  CAS  Google Scholar 

  53. Nakamura M, Kishi M, Sakaki T et al (2003) Novel tumor suppressor loci on 6q22-23 in primary central nervous system lymphomas. Cancer Res 63:737–741

    PubMed  CAS  Google Scholar 

  54. Rubenstein JL, Fridlyand J, Shen A et al (2006) Gene expression and angiotropism in primary CNS lymphoma. Blood 107:3716–3723

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Radiology, Haukeland University Hospital, Bergen, Norway, 5021

    Ingfrid Salvesen Haldorsen

  2. Department of Neurology, Mayo Medical School, Mayo Clinic Cancer Center, Rochester, MN, 55905, USA

    Brian Patrick O’Neill

Authors
  1. Ingfrid Salvesen Haldorsen
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Brian Patrick O’Neill
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Brian Patrick O’Neill .

Editor information

Editors and Affiliations

  1. , Stephen E. and Catherine Pappas Center f, Massachusetts General Hospital, Fruit St. 55, Boston, 02114, Massachusetts, USA

    Tracy Batchelor

  2. Dept. Neurology, Memorial Sloan-Kettering Cancer Center, York Ave. 1275, New York, 10021-6007, New York, USA

    Lisa M. DeAngelis

Rights and permissions

Reprints and permissions

Copyright information

© 2012 Springer Science+Business Media, LLC

About this chapter

Cite this chapter

Haldorsen, I.S., O’Neill, B.P. (2012). Epidemiology of Primary Central Nervous System Lymphoma. In: Batchelor, T., DeAngelis, L. (eds) Lymphoma and Leukemia of the Nervous System. Springer, New York, NY. https://doi.org/10.1007/978-1-4419-7668-0_4

Download citation

Publish with us

Policies and ethics

Search

Navigation